<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/"><channel><title>医学新闻</title><description>来自 News-Medical.Net - 来自世界各地的最新医学新闻和研究</description><link/>https://www.news-medical.net/<language> en-GB</language><item><title>研究揭示了小鼠口腔细菌与胰腺癌发展之间的联系</title><description>新研究揭示了小鼠口腔细菌与胰腺癌发展之间的显着联系，并揭示了先前公认的口腔健康与胰腺癌（最致命的癌症之一）之间的联系。</description><link/> https://www.news-medical.net/news/20240326/Study-unveils-link- Between-oral-bacteria-and-pancreatic-cancer-development-in-mice.aspx<comments> https://www.news-medical.net/news/20240326/Study-unveils-link- Between-oral-bacteria-and-pancreatic-cancer-development-in-mice.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=caa4435c-cd33-48b8-9e30-a5ffe32f7575</guid><pubDate> Tue, 26 Mar 2024 13:13:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2015/3/Pancreatic_Cancer_89a89cdc7f804d5b8329b646f86bbec6-620x480.jpg" width="620"><media:description><![CDATA[Study unveils link between oral bacteria and pancreatic cancer development in mice]]></media:description></media:content></item><item><title>加州大学研究人员启动二期临床试验，测试胶质母细胞瘤的新组合疗法</title><description>辛辛那提大学癌症中心研究人员组成的多学科团队已经启动了一项二期临床试验，以测试一种针对胶质母细胞瘤（GBM）的新联合疗法，胶质母细胞瘤是最致命的脑肿瘤。</description><link/> https://www.news-medical.net/news/20240326/UC-researchers-open-Phase-2-clinical-trial-to-test-new-combination-treatment-for-glioblastomas.aspx<comments> https://www.news-medical.net/news/20240326/UC-researchers-open-Phase-2-clinical-trial-to-test-new-combination-treatment-for-glioblastomas.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=7b483bcd-2788-4bec-826a-2f9c09f0484c</guid><pubDate> Tue, 26 Mar 2024 13:09:40 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/174318220-620x480.jpg" width="620"><media:description><![CDATA[UC researchers open Phase 2 clinical trial to test new combination treatment for glioblastomas]]></media:description></media:content></item><item><title>研究揭示遗传变异与西班牙裔/拉丁裔儿童患白血病风险增加有关</title><description>急性淋巴细胞白血病 (ALL) 是最常见的儿童癌症，对美国西班牙裔/拉丁裔儿童的影响尤为严重。</description><link/> https://www.news-medical.net/news/20240326/Study-reveals-genic-variant-linked-to-increased-risk-of-leukemia-in-HispanicLatino-children.aspx<comments> https://www.news-medical.net/news/20240326/Study-reveals-genic-variant-linked-to-increased-risk-of-leukemia-in-HispanicLatino-children.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=045ac524-f66a-4940-9dcb-672bd2cdd2d4</guid><pubDate> Tue, 26 Mar 2024 13:02:12 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Leukemia-620x480.jpg" width="620"><media:description><![CDATA[Study reveals genetic variant linked to increased risk of leukemia in Hispanic/Latino children]]></media:description></media:content></item><item><title>童年久坐时间与血管过早损伤有关</title><description>一项新的研究显示，从儿童时期起久坐时间的增加与动脉僵硬度的恶化有关，动脉僵硬度是血管过早损伤的一个表现。</description><link/> https://www.news-medical.net/news/20240326/Sedentary-time-in-childhood-linked-with-premature-angio-damage.aspx<comments> https://www.news-medical.net/news/20240326/Sedentary-time-in-childhood-linked-with-premature-angio-damage.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=85327128-e4ff-429a-a94d-fee805e5c409</guid><pubDate> Tue, 26 Mar 2024 12:52:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/7/Physical_Activity-620x480.jpg" width="620"><media:description><![CDATA[Sedentary time in childhood associated with premature vascular damage]]></media:description></media:content></item><item><title>研究表明葫芦巴碱可作为衰老过程中线粒体功能障碍的治疗剂</title><description>肌肉减少症是由于肌纤维消耗而导致的与年龄相关的骨骼肌衰退。</description><link/> https://www.news-medical.net/news/20240326/Study-reveals-trigonelline-as-a-therapeutic-agent-for-mitochondrial-dysfunction-in-aging.aspx<comments> https://www.news-medical.net/news/20240326/Study-reveals-trigonelline-as-a-therapeutic-agent-for-mitochondrial-dysfunction-in-aging.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=04e9c618-36aa-4a25-8c06-5c6f0bc3b419</guid><pubDate> Tue, 26 Mar 2024 10:34:00 -0400</pubDate> <media:content expression="full" height="1332" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/images/news/ImageForNews_775540_17114635620183913.jpg" width="2000"><media:description><![CDATA[Study reveals trigonelline as a therapeutic agent for mitochondrial dysfunction in aging]]></media:description></media:content></item><item><title> Viroclinics-DDL 更名为 Cerba Research</title><description> Viroclinics-DDL 是一家世界领先的疫苗和抗病毒专业实验室，提供植根于病毒学的研究和临床试验解决方案，自豪地宣布自 2024 年 4 月 1 日起更名为 Cerba Research。</description><link/> https://www.news-medical.net/news/20240326/Viroclinics-DDL-changes-name-to-Cerba-Research.aspx<comments> https://www.news-medical.net/news/20240326/Viroclinics-DDL-changes-name-to-Cerba-Research.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=7fdb75a3-d6b7-48c5-be1d-37716a2da034</guid><pubDate> Tue, 26 Mar 2024 10:06:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2016/6/Chem_Lab_c618f8c3be2845828afd242b15eaaa94-620x480.jpg" width="620"><media:description><![CDATA[Viroclinics-DDL changes name to Cerba Research]]></media:description></media:content></item><item><title> Teva UK 和 Closed Loop Medicine 宣布建立战略合作伙伴关系，以推动个性化药物的开发</title><description>Teva UK Limited 和 Closed Loop Medicine Ltd 宣布建立战略合作伙伴关系，以推动个性化医疗的发展。</description><link/> https://www.news-medical.net/news/20240326/Teva-UK-and-Closed-Loop-Medicine-announce-strategic-partnership-to-advance-development-of-personalized-medicines.aspx<comments> https://www.news-medical.net/news/20240326/Teva-UK-and-Closed-Loop-Medicine-announce-strategic-partnership-to-advance-development-of-personalized-medicines.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8a4acd58-18ef-48c1-b211-4de588ca50e7</guid><pubDate> Tue, 26 Mar 2024 09:58:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2014/6/Prescription_Drug-620x480.jpg" width="620"><media:description><![CDATA[Teva UK and Closed Loop Medicine announce strategic partnership to advance development of personalised medicines]]></media:description></media:content></item><item><title> Charpentier/Doudna CRISPR关键专利获中国国家知识产权局维持</title><description>RS Genomics Limited 的成立是为了提供对 Emmanuelle Charpentier 博士共同拥有的基础 CRISPR/Cas9 知识产权的广泛访问，今天宣布其专利 CN201380038920.6 获得 CNIPA 的支持，以应对无效挑战。</description><link/> https://www.news-medical.net/news/20240326/Key-CharpentierDoudna-CRISPR-patent-upheld-by-China-National-Intellectual-Property-Administration.aspx<comments> https://www.news-medical.net/news/20240326/Key-CharpentierDoudna-CRISPR-patent-upheld-by-China-National-Intellectual-Property-Administration.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=0b1a760a-c70d-4009-824f-97bab4d4e843</guid><pubDate> Tue, 26 Mar 2024 09:51:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/CRISPR_locus_on_DNA_sequence-Catalin_Rusnac_51742dddb09c41d2924841b1b4decc7a-620x480.jpg" width="620"><media:description><![CDATA[Key Charpentier/Doudna CRISPR patent upheld by China National Intellectual Property Administration]]></media:description></media:content></item><item><title> Ubiquigent 和 Debiopharm 达成协议，支持 Debio 0432 的 USP1 抑制剂项目</title><description>该项目将展示 Ubiquigent 以 DUB 为中心的平台如何支持 DUB 抑制剂从发现到临床开发的整个过程。</description><link/> https://www.news-medical.net/news/20240326/Ubiquigent-and-Debiopharm-enter-agreement-to-support-USP1-inhibitor-programme-for-Debio-0432.aspx<comments> https://www.news-medical.net/news/20240326/Ubiquigent-and-Debiopharm-enter-agreement-to-support-USP1-inhibitor-programme-for-Debio-0432.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=68d1aea4-3fe8-4d88-8fc6-e928fa2cbf48</guid><pubDate> Tue, 26 Mar 2024 09:48:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2019/5/Drug_use_and_prohibited_substances._-_Image_-_Monika_Gruszewicz_A1_b3acfd6d2daf44ecbd36979af20eb378-620x480.jpg" width="620"><media:description><![CDATA[Ubiquigent and Debiopharm enter agreement to support USP1 inhibitor programme for Debio 0432]]></media:description></media:content></item><item><title> Bio-Rad 推出用于稀有细胞和循环肿瘤细胞计数的经过验证的抗体</title><description>抗体经过验证可与 Bio-Rad 的 Celselect Slides™ 计数染色试剂盒一起使用，以便对液体活检样本中捕获的循环肿瘤细胞进行免疫染色。</description><link/> https://www.news-medical.net/news/20240326/Bio-Rad-launches-validated-antibodies-for-rare-cell-and-circulate-tumor-cell-enumeration.aspx<comments> https://www.news-medical.net/news/20240326/Bio-Rad-launches-validated-antibodies-for-rare-cell-and-circulate-tumor-cell-enumeration.aspx#comment</comments><guid> https://www.news-medical.net/post.aspx?id=8411a7c6-f073-41a0-b333-52c74e921b5c</guid><pubDate> Tue, 26 Mar 2024 09:44:00 -0400</pubDate> <media:content expression="full" height="480" type="image/jpeg" url="https://d2jx2rerrg6sh3.cloudfront.net/image-handler/picture/2018/7/antibody_in_pink_and_red_background_selective_focus_3d_art_-_Mirror-Images_A1_71b890c58eb74b42a6490cfe1b003dce-620x480.jpg" width="620"><media:description><![CDATA[Bio-Rad launches validated antibodies for rare cell and circulating tumor cell enumeration]]></media:description></media:content></item></channel></rss>